Skip to main content

Blog

Edgewise Announces 4-Month Interim Results from ARCH Open Label Study of EDG-5506 in Adults with Becker

...

Edgewise Announces FDA Authorization for Phase 2 Clinical Trial of EDG-5506 in Participants with Duchenne

...

The Duchenne Registry: Advancing Research for Female Carriers

...

World Duchenne Awareness Day 2022: Stories of #WomenAndDuchenne

...

Dyne Therapeutics Announces First Patient Dosed in Phase 1/2 DELIVER Clinical Trial of DYNE-251

...

Dr. Mena Scavina: My Story as a Clinician #WomenAndDuchenne

...

Pat Furlong: My Story as a Mom, Finding the Power of ‘Us’ #WomenAndDuchenne

...

Mariana: My Story as a Carrier with Cardiac Concerns #WomenAndDuchenne

...

Deb: My Story as a Mom to Daughters Living with Duchenne #WomenAndDuchenne

...

Sarepta Therapeutics Announces That FDA has Lifted its Clinical Hold on SRP-5051

...